Integrating New Data From CROI 2021

Join 2 leading experts for an interactive Webinar focused on the most clinically relevant data presented at CROI 2021, as well as other key studies that may be significant to the advancement of HIV patient care. Case vignettes will be used to explore integration of findings into everyday patient management.

April 6, 2021 at 12:00 PM – For clinicians in the Carolinas

April 6, 2021 at 4:00 PM – For clinicians in the Midwest

April 7, 2021 at 12:00 PM – For clinicians in the Western US

April 7, 2021 at 4:00 PM – For clinicians in New Jersey

April 13, 2021 at 12:00 PM – For clinicians in Florida

April 13, 2021 at 4:00 PM – For clinicians in the Virginias

April 14, 2021 at 12:00 PM – For clinicians in New England

April 14, 2021 at 6:00 PM – For clinicians in the Southeast

April 15, 2021 at 12:00 PM – For clinicians in Pennsylvania

April 15, 2021 at 4:00 PM – For clinicians in Southwest

Agenda

The timing and agenda for each webinar is as follows:

  • Introduction and Program Overview (5 mins)
  • Key Findings from CROI 2021 (60 minus)
  • Question and Answer Session (25 mins)

Faculty

Program Director
Joseph J. Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy N. Kumar, MD

Professor of Medicine and Microbiology
Chief, 
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Faculty
Jonathan Appelbaum, MD

Laurie L. Dozier Jr, MD, Education Director
Professor of Internal Medicine
Chair,
Department of Clinical Sciences
Florida State University College of Medicine
Tallahassee, Florida

Faculty
Roger Bedimo, MD

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Faculty
Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California, San Francisco
Medical Director
Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

Faculty
Jason Halperin, MD, MPH

Assistant Professor of Medicine
Department of Infectious Diseases
Tulane University
Infectious Disease Physician
CrescentCare
New Orleans, Louisiana

Faculty
W. David Hardy, MD

Scientific and Medical Consultant
Adjunct Professor of Medicine

Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Faculty
Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Faculty
Mary W. Montgomery, MD

Instructor of Medicine
Harvard Medical School
Associate Professor
Division of Infectious Disease
Department of Medicine
Brigham and Women's Hospital
Boston, Massachusetts

Faculty
Paul Sax, MD

Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Faculty
Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
University of Chicago
Chicago, Illinois

Faculty
William Short, MD

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Faculty
Shobha Swaminathan, MD

Associate Professor
Division of Infectious Diseases
Department of Medicine
Rutgers New Jersey Medical School
Newark, New Jersey

Faculty
Alan Taege, MD

Assistant Professor of Medicine
Department of Medicine
Cleveland Clinic Lerner College of Medicine
Staff Physician
Department of Infectious Disease
Cleveland Clinic
Cleveland, Ohio

Faculty
Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, 
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Faculty
Timothy Wilkin, MD

Associate Professor of Medicine
Co-Director, Cornell Clinical Trials Unit
Weill Cornell Medical College
New York, New York

Faculty
David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader,  AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate best practices in the management of first-line ART and regimen modifications in virologically suppressed patients
  • Apply optimized management strategies for patients with HIV with virologic failure in the setting of an extensive treatment history and multiclass drug resistance
  • Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection, as appropriate
  • Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-21-006-L02-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.